いぼ治療薬市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPRE00024332
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 401
Buy Now

いぼ治療薬市場は、2021 年に 18 億 2,954 万米ドルと評価され、2021 年から 2028 年にかけて 3.4% の CAGR で成長すると推定されています。



いぼ治療薬市場の成長は、上昇によるものと考えられます。ヒトパピローマウイルス感染症の蔓延と性器いぼの再発、および新製品の開発。ただし、低所得国における貧弱な診断シナリオが市場の成長を抑制します。いぼは、ヒトパピローマウイルス (HPV) によって引き起こされる皮膚の増殖です。 HPV には 60 種類以上あり、そのうちのいくつかは皮膚にイボを引き起こす傾向があります。局所治療は副作用を最小限に抑えながら、おそらく数週間でイボの問題を解決できる可能性がありますが、常に効果があるとは限りません。したがって、液体窒素を使用した凍結療法は治療に適した選択肢であり、治癒率は 60 ~ 90%、再発率は 10 ~ 20% 未満です。 COVID 19。パンデミックは、世界のサプライチェーン、消費者市場、そして経済全体に大混乱を引き起こしています。世界中の政府が実施した措置の結果、いぼ治療薬市場の成長に悪影響を及ぼしています。



いぼ治療薬市場にとって有利な地域

市場洞察上昇ヒトパピローマウイルス感染症の蔓延と性器疣贅の再発いぼ治療薬市場の成長を促進いぼはさまざまな株のヒトパピローマウイルス(HPV)によって引き起こされ、株が異なれば体のさまざまな部分にイボが生じます。健康な人がいぼに触れると感染する可能性があります。アメリカ疾病予防管理センター (CDC) によると、2018 年には米国の人口の約 20%、つまり約 4,250 万人が性感染症 (STI) に罹っていました。さらに、HPV ワクチン接種以前には、米国では毎年約 340,000 ~ 360,000 人の女性と男性が性器疣贅に罹患していました。さらに、性器疣贅は再発率が高いです。国立バイオテクノロジー情報センター (NCBI) によると、世界中のいぼ症例の約 30% が感染後最初の 4 か月以内に退縮すると予想されています。さらに、HPV 感染は子宮頸がんの原因となり、子宮頸がんは世界の女性で 4 番目に多いがんです。世界保健機関(WHO)によると、2018年には子宮頸がんの新たな症例が約57万人記録され、低所得国での罹患率が高かった。したがって、HPV感染症の有病率の増加がイボの症例の増加につながり、イボの高い再発率がイボ治療薬市場の成長を推進しています。タイプベースの洞察タイプに基づいて、イボ治療薬市場はさらに一般的なものに分類されます。イボ、生殖器イボ、扁平イボなど。尋常性疣贅セグメントは市場で最大のシェアを占めています。ただし、生殖器疣贅セグメントは、2021 年から 2028 年にかけて最も高い CAGR を記録すると予想されます。性器いぼは、通常 HPV によって引き起こされる性感染症を指します。 STDの有病率の増加と、性器いぼの治療選択肢を開発するための研究開発の取り組みの拡大により、今後数年間でこのセグメントの市場の成長が促進されるでしょう。



タイプ別のいぼ治療薬市場 - 2021年および2028年

治療 - ベースの洞察治療に基づいて、いぼ治療薬市場はさらに物理的破壊、免疫調節、化学的破壊に分類されます。物理的破壊の市場は、凍結療法、外科的除去、レーザー治療にさらに分類されます。免疫調節は、インターフェロン、レチノイド、亜鉛にサブセグメント化されています。化学的破壊セグメントは、ブレオマイシン、カンタリジン、サリチル酸などにさらに分類されます。物理的破壊セグメントは、いぼ治療薬市場で最大のシェアを占めており、予測期間中に市場で最高のCAGRを記録すると予想されています。エンドユーザーベースの洞察エンドユーザーに基づいて、いぼ治療薬市場は病院、在宅医療、専門分野に分類されます。クリニック、その他。病院部門が最大の市場シェアを占めています。ただし、在宅ケアセグメントは、予測期間中に最も高い CAGR を記録すると推定されています。このセグメントの市場成長が予測されるのは、世界中で病院の数が増加し、外科手術の数が急速に増加していることが原因であると考えられます。戦略的洞察いぼ治療市場で事業を展開している企業は、世界中で進化する顧客の需要を満たすために製品イノベーション戦略を採用しています。



イボ治療市場 - 種類別





  • 尋常性疣贅

  • 性器疣贅

  • 扁平疣贅

  • その他


いぼ治療市場 - 治療別





  • 物理的破壊

      < li>凍結療法
    • 外科的切除

    • レーザー治療



  • 免疫調節

    • インターフェロン

    • >レチノイド

    • 亜鉛



  • 化学的破壊

    • ブレオマイシン

    • カンタリジン

    • サリチル酸酸

    • その他




いぼ治療市場 - エンドユーザー別





  • 病院

  • 在宅ケア

  • 専門クリニック

  • その他


いぼ治療薬市場 - 地理別





  • 北米

    • 米国

    • カナダ

    • メキシコ



  • ヨーロッパ

    • フランス

    • ドイツ

    • イタリア

    • 英国

    • スペイン

    • その他のヨーロッパ



  • アジア太平洋 (APAC)

    • 中国

    • インド

    • 韓国

    • 日本

    • オーストラリア
    • アジア太平洋地域のその他の地域



  • 中東およびアフリカ (MEA)

    • 南アフリカ

    • サウジアラビア

    • >
    • UAE

    • MEA の残りの部分



  • 中南米 (SCAM)

    • ブラジル

    • アルゼンチン

    • その他の詐欺行為




会社概要





  • Bausch Health Companies Inc.

  • li>
  • Nielsen BioSciences, Inc.

  • Euro Vital Pharma GmbH

  • Cipla Inc.

  • Koninklijke Utermöhlen NV

  • Novan, Inc.

  • Scholl's Wellness Company

  • TEVA PHARMACEUTICAL INDUSTRIES LTD

  • Verrica Pharmaceuticals Inc.

  • GlaxoSmithKline plc.

  • AIM イムノテック株式会社


Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are warts therapeutics?

Warts are skin growth caused by the human papillomavirus (HPV). There are more than 60 types of HPV, some of which tend to cause warts on the skin. Topical treatments could probably resolve the issue of warts in a few weeks with minimal side effects. Topical treatment of may not be effective all the time. Hence, cryotherapy with liquid nitrogen is a suitable option for treatment, where cure rate is 60% to 90% with less than 20% to 10% recurrence rate.

What are the driving factors for the Warts Therapeutics market across the globe?

The factors that are driving growth of the market are rising prevalence of human papillomavirus infections and recurrence of genital warts and new product developments.

Who are the developments carrying out by major players in the warts therapeutics market?

Various companies have made organic growth strategies in the warts therapeutics market. Some of the activities undertaken by the company, which have promoted its growth are, launches, enhancements and expansion & relocation activities. Companies such as Nielsen BioSciences, Inc, TEVA PHARMACEUTICAL INDUSTRIES LTD amongst others are some of the companies that have been implementing various organic strategies that have helped the growth of the company.

Which region is dominated the warts therapeutics market?

North America dominates the global warts therapeutics market due to factors such as rising prevalence of HPV, increasing product launches, well-developed healthcare facility centres equipped with modern-age equipment and instruments.

Which segment is growing at the highest CAGR in the Warts Therapeutics market?

The physical destruction segment is growing at the highest CAGR owing to availability of diagnostic devices and ease offered by these devices for diagnosis of various disorders.

Which region is the fastest growing in the Warts Therapeutics market?

Asia Pacific is expected to be the fastest growing region in the warts therapeutics market. The growth of the market in this region is primarily due to supportive government initiatives and research in the field of HPV infection.

The List of Companies - Warts Therapeutics Market

  1. Bausch Health Companies Inc.            
  2. Nielsen BioSciences, Inc.        
  3. Euro Vital Pharma GmbH        
  4. Cipla Inc.       
  5. Koninklijke Utermöhlen NV      
  6. Novan, Inc.    
  7. Scholl's Wellness Company    
  8. TEVA PHARMACEUTICAL INDUSTRIES LTD               
  9. Verrica Pharmaceuticals Inc.    
  10. GlaxoSmithKline plc.              
  11. AIM ImmunoTech Inc

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports